{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:49:23Z","timestamp":1793922563219,"version":"4.8.0"},"reference-count":245,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.neuropharm.2025.110314","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T11:04:48Z","timestamp":1737198288000},"page":"110314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Exploring DMT: Endogenous role and therapeutic potential"],"prefix":"10.1016","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3355-1153","authenticated-orcid":false,"given":"Jakub","family":"Schimmelpfennig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Jankowiak-Siuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib1","doi-asserted-by":"crossref","first-page":"C178","DOI":"10.1152\/ajpcell.00381.2001","article-title":"Role of nitric oxide in the regulation of HIF-1\u03b1 expression during hypoxia","volume":"283","author":"Agani","year":"2002","journal-title":"Am. J. Physiol.: Cell Physiol."},{"key":"10.1016\/j.neuropharm.2025.110314_bib2","first-page":"190","article-title":"B-Carbolines, psychoactive compounds in the mammalian body","volume":"59","author":"Airaksinen","year":"1981","journal-title":"Med. Biol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110314_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1600-0773.1978.tb02281.x","article-title":"The uptake of 6\u2010Methoxy\u20101,2,3,4\u2010Tetrahydro\u2010\u03b2\u2010carboline and its effect on 5\u2010hydroxytryptamine uptake and release in blood platelets","volume":"43","author":"Airaksinen","year":"1978","journal-title":"Acta Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110314_bib4","article-title":"DMT alters cortical travelling waves","volume":"9","author":"Alamia","year":"2020","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.STR.18.3.649","article-title":"Cerebral effects of extended hyperventilation in unanesthetized goats","volume":"18","author":"Albrecht","year":"1987","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41380-023-02360-0","article-title":"Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential","volume":"29","author":"Allen","year":"2024","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110314_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136528","article-title":"Activation of the sigma-1 receptor attenuates blood\u2013brain barrier disruption by inhibiting amyloid deposition in Alzheimer's disease mice","volume":"774","author":"An","year":"2022","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1196\/annals.1304.020","article-title":"Characterization of [ 3 H]harmane binding to rat whole brain membranes","volume":"1009","author":"Anderson","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuropharm.2005.08.022","article-title":"In vitro and ex vivo distribution of [3H]harmane, an endogenous \u03b2-carboline, in rat brain","volume":"50","author":"Anderson","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110314_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-017-0186-6","article-title":"Psychoactive substances as a last resort\u2014a qualitative study of self-treatment of migraine and cluster headaches","volume":"14","author":"Andersson","year":"2017","journal-title":"Harm Reduct. J."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110314_bib13","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1016\/S0021-9258(17)35612-0","article-title":"Amine N-methyltransferases from rabbit liver","volume":"261","author":"Ansher","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110314_bib14","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.5665\/sleep.5000","article-title":"The role of the serotonergic system in REM sleep behavior disorder","volume":"38","author":"Arnaldi","year":"2015","journal-title":"Sleep"},{"issue":"3475","key":"10.1016\/j.neuropharm.2025.110314_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1126\/science.134.3475.343","article-title":"Enzymatic Formation of psychotomimetic metabolites from normally occurring compounds","volume":"134","author":"Axelrod","year":"1961","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110314_bib16","article-title":"Effects of conscious connected breathing on cortical brain activity, mood and state of consciousness in healthy adults","author":"Bahi","year":"2023","journal-title":"Curr. Psychol."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110314_bib18","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/neu.480251107","article-title":"The Trk family of neurotrophin receptors","volume":"25","author":"Barbacid","year":"1994","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110314_bib19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fnins.2018.00536","article-title":"N, N-dimethyltryptamine (DMT), an endogenous hallucinogen: past, present, and future research to determine its role and function","volume":"12","author":"Barker","year":"2018","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110314_bib20","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00213-022-06065-0","article-title":"Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT","volume":"239","author":"Barker","year":"2022","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110314_bib21","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0006-2952(84)90404-0","article-title":"In vivo metabolism of \u03b1,\u03b1,\u03b2,\u03b2-tetradeutero-n, N-dimethyltryptamine in rodent brain","volume":"33","author":"Barker","year":"1984","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110314_bib22","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/bmc.2981","article-title":"LC\/MS\/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate: LC\/MS\/MS of endogenous DMTs in rat pineal gland microdialysate","volume":"27","author":"Barker","year":"2013","journal-title":"Biomed. Chromatogr."},{"issue":"7\u20138","key":"10.1016\/j.neuropharm.2025.110314_bib23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/dta.422","article-title":"A critical review of reports of endogenous psychedelic N, N\u2010dimethyltryptamines in humans: 1955\u20132010","volume":"4","author":"Barker","year":"2012","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.neuropharm.2025.110314_bib24","article-title":"Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans","volume":"113928","author":"Barman","year":"2023","journal-title":"Phytochemistry"},{"key":"10.1016\/j.neuropharm.2025.110314_bib25","first-page":"1322","volume":"vol. 4","author":"Beaton","year":"1977"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0047-6374(84)90007-1","article-title":"Ontogeny of N,N-Dimethyltryptamine and related indolealkylamine levels in neonatal rats","volume":"25","author":"Beaton","year":"1984","journal-title":"Mech. Ageing Dev."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib27","first-page":"120","article-title":"A high-resolution in vivo atlas of the human brain's serotonin system","volume":"37","author":"Beliveau","year":"2017","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11064-022-03767-x","article-title":"Acute hypobaric hypoxia exposure causes neurobehavioral impairments in rats: role of brain catecholamines and tetrahydrobiopterin alterations","volume":"48","author":"Bhattacharjee","year":"2023","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1471-4159.1975.tb07653.x","article-title":"Indolamine N \u2010methyltransferase activity in human tissues 1","volume":"24","author":"Bhikharidas","year":"1975","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110314_bib30","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/adc.49.10.766","article-title":"Mothers' attitudes to preterm infants","volume":"49","author":"Bidder","year":"1974","journal-title":"Arch. Dis. Child."},{"issue":"21","key":"10.1016\/j.neuropharm.2025.110314_bib31","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1007\/s00213-014-3557-7","article-title":"Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes","volume":"231","author":"Blough","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110314_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/02698811241276788","article-title":"Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being","author":"Bonnelle","year":"2024","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110314_bib33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ana.410270608","article-title":"Net production of cerebrospinal fluid is decreased by SCH-23390","volume":"27","author":"Boyson","year":"1990","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pnpbp.2012.06.001","article-title":"Developments in harmine pharmacology\u2014implications for ayahuasca use and drug-dependence treatment","volume":"39","author":"Brierley","year":"2012","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110314_bib35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/ph13110334","article-title":"Toxicokinetics and toxicodynamics of ayahuasca alkaloids N,N-dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine: clinical and forensic impact","volume":"13","author":"Brito-da-Costa","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0896-6273(00)00097-0","article-title":"Quantal release of serotonin","volume":"28","author":"Bruns","year":"2000","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110314_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pneurobio.2006.07.003","article-title":"The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain","volume":"79","author":"Burchett","year":"2006","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","article-title":"Towards an understanding of psychedelic-induced neuroplasticity","volume":"48","author":"Calder","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0306-9877(88)90064-3","article-title":"A proposed mechanism for the visions of dream sleep","volume":"26","author":"Callaway","year":"1988","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/02791072.2005.10399795","article-title":"Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis","volume":"37","author":"Callaway","year":"2005","journal-title":"J. Psychoact. Drugs"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jhet.5570310231","article-title":"The pictet\u2010spengler reaction and biogenic tryptamines: formation of tetrahydro\u2010\u03b2\u2010carbolines at physiological p H","volume":"31","author":"Callaway","year":"1994","journal-title":"J. Heterocycl. Chem."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110314_bib43","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/acschemneuro.8b00692","article-title":"Chronic, intermittent microdoses of the psychedelic N , N -dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents","volume":"10","author":"Cameron","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110314_bib44","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acschemneuro.8b00134","article-title":"Effects of N , N -dimethyltryptamine on rat behaviors relevant to anxiety and depression","volume":"9","author":"Cameron","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00213-014-3658-3","article-title":"The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice","volume":"232","author":"Carbonaro","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110314_bib46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N,N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib47","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol. Rev."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110314_bib48","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/0269881117725915","article-title":"Serotonin and brain function: a tale of two receptors","volume":"31","author":"Carhart-Harris","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/dta.2197","article-title":"Metabolism of the tryptamine\u2010derived new psychoactive substances 5\u2010MeO\u20102\u2010Me\u2010DALT, 5\u2010MeO\u20102\u2010Me\u2010ALCHT, and 5\u2010MeO\u20102\u2010Me\u2010DIPT and their detectability in urine studied by GC\u2013MS, LC\u2013MS n , and LC\u2010HR\u2010MS\/MS","volume":"10","author":"Caspar","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110314_bib50","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/rapm-2020-101273","article-title":"Chronic pain and psychedelics: a review and proposed mechanism of action","volume":"45","author":"Castellanos","year":"2020","journal-title":"Reg. Anesth. Pain Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4331\/wjbc.v4.i4.141","article-title":"Changes in aminoacidergic and monoaminergic neurotransmission in the hippocampus and amygdala of rats after ayahuasca ingestion","volume":"4","author":"Castro-Neto","year":"2013","journal-title":"World J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00221-013-3579-0","article-title":"Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning","volume":"228","author":"Catlow","year":"2013","journal-title":"Exp. Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-024-01462-3","article-title":"N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer's disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk","volume":"16","author":"Cheng","year":"2024","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuropharm.2025.110314_bib54","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0003-9861(70)90144-X","article-title":"Preparation and properties of a homogeneous aromatic L-amino acid decarboxylase from hog kidney","volume":"141","author":"Christenson","year":"1970","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-2944(75)90036-8","article-title":"Gas-liquid chromatographic separation and identification of biologically important indolealkylamines from human cerebrospinal fluid","volume":"14","author":"Christian","year":"1975","journal-title":"Biochem. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib56","first-page":"162","article-title":"Evidence for dimethyltryptamine (DMT) as a naturally-occurring transmitter in mammalian brain","volume":"13","author":"Christian","year":"1976","journal-title":"Ala. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib57","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0006-2944(77)90088-6","article-title":"The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent","volume":"18","author":"Christian","year":"1977","journal-title":"Biochem. Med."},{"issue":"18","key":"10.1016\/j.neuropharm.2025.110314_bib58","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1021\/bi500175p","article-title":"Noncompetitive inhibition of indolethylamine- N -methyltransferase by N , N -dimethyltryptamine and N , N -dimethylaminopropyltryptamine","volume":"53","author":"Chu","year":"2014","journal-title":"Biochemistry"},{"issue":"S1","key":"10.1016\/j.neuropharm.2025.110314_bib59","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1096\/fasebj.29.1_supplement.1022.7","article-title":"Methylation of thiols and thioethers by human indolethylamine-N methyl transferase","volume":"29","author":"Chu","year":"2015","journal-title":"Faseb. J."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/hmg\/ddm286","article-title":"Brain-specific tryptophan hydroxylase 2 (TPH2): a functional Pro206Ser substitution and variation in the 5\u2019-region are associated with bipolar affective disorder","volume":"17","author":"Cichon","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2025.110314_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fspor.2021.700757","article-title":"Acute effects of the Wim hof breathing method on repeated sprint ability: a pilot study","volume":"3","author":"Citherlet","year":"2021","journal-title":"Frontiers in Sports and Active Living"},{"key":"10.1016\/j.neuropharm.2025.110314_bib62","series-title":"Triptamina e dimetiltriptamina em melanomas: Bioss\u00edntese, metaboliza\u00e7\u00e3o e atividades antitumorais [Mestrado em Toxicologia e An\u00e1lises Toxicol\u00f3gicas","author":"Coimbra","year":"2012"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib63","first-page":"605","article-title":"Interaction of psychoactive drugs with the Mg+2 requiring ATPase associated with isolated synaptic vesicles","volume":"11","author":"Corbett","year":"1975","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P","article-title":"Cellular and subcellular distribution of the serotonin 5\u2010HT2A receptor in the central nervous system of adult rat","volume":"409","author":"Cornea\u2010H\u00e9bert","year":"1999","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0306-4522(02)00146-X","article-title":"Similar ultrastructural distribution of the 5-HT2A serotonin receptor and microtubule-associated protein MAP1A in cortical dendrites of adult rat","volume":"113","author":"Cornea-Hebert","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110314_bib66","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bbrc.2023.08.043","article-title":"A mechanistic insight for the biosynthesis of N,N-dimethyltryptamine: an ONIOM theoretical approach","volume":"678","author":"Coutinho","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2025.110314_bib67","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00702-009-0308-8","article-title":"Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter","volume":"116","author":"Cozzi","year":"2009","journal-title":"Journal of Neural Transmission (Vienna, Austria : 1996)"},{"issue":"840.19","key":"10.1016\/j.neuropharm.2025.110314_bib68","article-title":"Indolethylamine N-methyltransferase expression in primate nervous tissue","volume":"37","author":"Cozzi","year":"2011"},{"key":"10.1016\/j.neuropharm.2025.110314_bib69","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00232-020-00158-7","article-title":"Compartmentalized GPCR signaling from intracellular membranes","volume":"254","author":"Crilly","year":"2021","journal-title":"J. Membr. Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12779-5","article-title":"Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT","volume":"7","author":"Dakic","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110314_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146284","article-title":"Regulation of c-Fos gene transcription by stimulus-responsive protein kinases","volume":"821","author":"Dalh\u00e4usser","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.neuropharm.2025.110314_bib72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.phrs.2016.08.022","article-title":"The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors","volume":"113","author":"De Gregorio","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110314_bib73","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acschemneuro.5b00041","article-title":"Neurogenic potential assessment and pharmacological characterization of 6-Methoxy-1,2,3,4-tetrahydro-\u03b2-carboline (pinoline) and melatonin\u2013pinoline hybrids","volume":"6","author":"De La Fuente Revenga","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110314_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.724606","article-title":"Psychedelics and neuroplasticity: a systematic review unraveling the biological underpinnings of psychedelics","volume":"12","author":"De Vos","year":"2021","journal-title":"Front. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib75","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1038\/s41598-019-45812-w","article-title":"Biosynthesis and extracellular concentrations of N,N-dimethyltryptamine (DMT) in mammalian brain","volume":"9","author":"Dean","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110314_bib76","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuropharm.2013.02.005","article-title":"The two faces of the pharmacological interaction of mGlu2 and 5-HT2A\u2013relevance of receptor heterocomplexes and interaction through functional brain pathways","volume":"70","author":"Delille","year":"2013","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib77","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1152\/jappl.1975.38.4.665","article-title":"Effects of moderate hypoxemia and hypocapnia on CSF [H+] and ventilation in man","volume":"38","author":"Dempsey","year":"1975","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110314_bib78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainresbull.2016.03.002","article-title":"Ayahuasca: pharmacology, neuroscience and therapeutic potential","volume":"126","author":"Dom\u00ednguez-Clav\u00e9","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib79","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00213-011-2434-x","article-title":"Pharmacology of ayahuasca administered in two repeated doses","volume":"219","author":"Dos Santos","year":"2012","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110314_bib80","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/JCP.0b013e31823607f6","article-title":"Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine","volume":"31","author":"Dos Santos","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110314_bib81","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/s41386-022-01344-y","article-title":"Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder","volume":"47","author":"D'Souza","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110314_bib82","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/02698811221104050","article-title":"\u03b2-carboline-independent antidepressant-like effect of the standardized extract of the barks of Mimosa tenuiflora (Willd) Poir. Occurs via 5-HT 2A\/2C receptors in mice","volume":"36","author":"Duarte-Filho","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib84","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/cne.903370409","article-title":"Distribution of aromatic L\u2010amino acid decarboxylase mRNA in mouse brain by in situ hybridization histology","volume":"337","author":"Eaton","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110314_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114642","article-title":"Development and application of a highly sensitive LC-MS\/MS method for simultaneous quantification of N,N-dimethyltryptamine and two of its metabolites in human plasma","volume":"212","author":"Eckern\u00e4s","year":"2022","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.neuropharm.2025.110314_bib86","article-title":"N,N\u2010dimethyltryptamine affects electroencephalography response in a concentration\u2010dependent manner\u2014a pharmacokinetic\/pharmacodynamic analysis","volume":"psp4","author":"Eckern\u00e4s","year":"2023","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib87","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00018-024-05353-6","article-title":"Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors","volume":"81","author":"Egger","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"7321","key":"10.1016\/j.neuropharm.2025.110314_bib88","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature09612","article-title":"Regulation of synaptic connectivity by glia","volume":"468","author":"Eroglu","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110314_bib89","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00213-013-3303-6","article-title":"Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function","volume":"231","author":"Eshleman","year":"2014","journal-title":"Psychopharmacology"},{"issue":"22","key":"10.1016\/j.neuropharm.2025.110314_bib90","doi-asserted-by":"crossref","first-page":"11028","DOI":"10.1073\/pnas.1821332116","article-title":"Serotonin regulates mitochondrial biogenesis and function in rodent cortical neurons via the 5-HT 2A receptor and SIRT1\u2013PGC-1\u03b1 axis","volume":"116","author":"Fanibunda","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110314_bib91","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/0006-2952(91)90240-6","article-title":"Neurocatin-induced inhibition of monoamine oxidase a in rat brain synaptosomes","volume":"42","author":"Fernandez-Novoa","year":"1991","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110314_bib92","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.immuni.2018.04.016","article-title":"The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity","volume":"48","author":"Filipello","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.neuropharm.2025.110314_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105453","article-title":"High ventilation breathwork practices: an overview of their effects, mechanisms, and considerations for clinical applications","volume":"155","author":"Fincham","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110314_bib94","doi-asserted-by":"crossref","DOI":"10.1177\/02698811231164707","article-title":"Effects of serotonergic psychedelics on mitochondria: transdiagnostic implications for mitochondria-related pathologies","author":"Fissler","year":"2023","journal-title":"J. Psychopharmacol."},{"issue":"5916","key":"10.1016\/j.neuropharm.2025.110314_bib96","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.1166127","article-title":"The hallucinogen N,N -dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator","volume":"323","author":"Fontanilla","year":"2009","journal-title":"Science"},{"issue":"4988","key":"10.1016\/j.neuropharm.2025.110314_bib97","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/2061052a0","article-title":"Tryptamine, N,N-dimethyltryptamine, N,N-Dimethyl-5-hydroxytryptamine and 5-methoxytryptamine in human blood and urine","volume":"206","author":"Franzen","year":"1965","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib99","first-page":"39","article-title":"The protective role of dimethyltryptamine and its analogues against ischemiareperfusion injury: commentary","volume":"2","author":"Frecska","year":"2021","journal-title":"The Neuroscience Chronicles"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110314_bib100","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00702-013-1024-y","article-title":"A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity","volume":"120","author":"Frecska","year":"2013","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuropharm.2025.110314_bib101","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymben.2023.05.006","article-title":"In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E. coli","volume":"78","author":"Friedberg","year":"2023","journal-title":"Metab. Eng."},{"key":"10.1016\/j.neuropharm.2025.110314_bib102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fpsyt.2018.00185","article-title":"Cortisol modulation by ayahuasca in patients with treatment resistant depression and healthy controls","volume":"9","author":"Galv\u00e3o","year":"2018","journal-title":"Front. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib103","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ijnp\/pyac074","article-title":"Default Mode network modulation by psychedelics: a systematic review","volume":"26","author":"Gattuso","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib104","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41598-023-27538-y","article-title":"Indolethylamine N-methyltransferase (INMT) is not essential for endogenous tryptamine-dependent methylation activity in rats","volume":"13","author":"Glynos","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110314_bib105","author":"Glynos"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib106","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bcp.2014.01.035","article-title":"Biosynthesis of N,N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases","volume":"88","author":"Gomes","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"26","key":"10.1016\/j.neuropharm.2025.110314_bib107","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1523\/JNEUROSCI.23-26-08836.2003","article-title":"Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex","volume":"23","author":"Gonz\u00e1lez-Maeso","year":"2003","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib108","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s13318-023-00822-y","article-title":"Pharmacokinetics of N,N-dimethyltryptamine in humans","volume":"48","author":"Good","year":"2023","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110314_bib109","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1007\/s00253-022-12028-4","article-title":"Aromatic L-amino acid decarboxylases: mechanistic features and microbial applications","volume":"106","author":"Han","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"13","key":"10.1016\/j.neuropharm.2025.110314_bib110","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.3390\/molecules26134105","article-title":"Melatonin, its metabolites and their interference with reactive nitrogen compounds","volume":"26","author":"Hardeland","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib111","doi-asserted-by":"crossref","first-page":"F28","DOI":"10.1152\/ajprenal.1990.258.1.F28","article-title":"Aromatic L-amino acid decarboxylase activity along the rat nephron","volume":"258","author":"Hayashi","year":"1990","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110314_bib112","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00023210-200418050-00001","article-title":"??-1 receptor ligands: potential in the treatment of neuropsychiatric disorders","volume":"18","author":"Hayashi","year":"2004","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib113","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER- mitochondrion interface regulate Ca2+ signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.neuropharm.2025.110314_bib114","doi-asserted-by":"crossref","first-page":"12336","DOI":"10.1016\/S0021-9258(17)39030-0","article-title":"Synthesis of N pi-methylhistamine and N alpha-methylhistamine by purified rabbit lung indolethylamine N-methyltransferase","volume":"260","author":"Herman","year":"1985","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000139317","article-title":"Comparison of the hallucinogenic indole alkaloids ibogaine and harmaline for potential immunomodulatory activity","volume":"51","author":"House","year":"1995","journal-title":"Pharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib116","doi-asserted-by":"crossref","DOI":"10.15761\/IMM.1000295","article-title":"Importance of D-neuron research in neuropsychiatry","volume":"4","author":"Ikemoto","year":"2017","journal-title":"Integrative Molecular Medicine"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110314_bib117","first-page":"126","article-title":"D-cell hypothesis of schizophrenia","volume":"6","author":"Ikemoto","year":"2023","journal-title":"Leading to Develop Non-D2 Receptor-Binding Antipsychotics. Adv Bioeng Biomed Sci Res"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib118","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3940(97)00587-9","article-title":"Demonstration of l-dopa decarboxylating neurons specific to human striatum","volume":"232","author":"Ikemoto","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib119","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(99)00409-7","article-title":"Tyrosine hydroxylase and aromatic l-amino acid decarboxylase do not coexist in neurons in the human anterior cingulate cortex","volume":"269","author":"Ikemoto","year":"1999","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0006-8993(98)00661-1","article-title":"Do all of human midbrain tyrosine hydroxylase neurons synthesize dopamine?","volume":"805","author":"Ikemoto","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110314_bib121","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fphar.2018.00330","article-title":"Hypothesis: the psychedelic ayahuasca heals traumatic memories via a sigma 1 receptor-mediated epigenetic-mnemonic process","volume":"9","author":"Inserra","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"4589","key":"10.1016\/j.neuropharm.2025.110314_bib122","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.6131537","article-title":"Some neurons of the rat central nervous system contain aromatic-L-amino-acid decarboxylase but not monoamines","volume":"219","author":"Jaeger","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110314_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1305796","article-title":"Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial","volume":"14","author":"James","year":"2024","journal-title":"Front. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib124","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neulet.2008.06.028","article-title":"5-HT2A\/2C receptor blockade regulates progenitor cell proliferation in the adult rat hippocampus","volume":"441","author":"Jha","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/2773-2398.386227","article-title":"Neuromodulatory mechanisms of N,N-dimethyltryptamine: a narrative review","volume":"2","author":"Jim\u00e9nez","year":"2023","journal-title":"Brain Network and Modulation"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110314_bib126","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/02698811221104054","article-title":"Significance of mammalian N, N-dimethyltryptamine (DMT): a 60-year-old debate","volume":"36","author":"Jim\u00e9nez","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110314_bib127","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1124\/mol.113.091165","article-title":"Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities","volume":"85","author":"Jin","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110314_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109422","article-title":"Ketamine and serotonergic psychedelics: an update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment","volume":"226","author":"Johnston","year":"2023","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110314_bib129","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.mehy.2012.07.029","article-title":"Serotonergic and tryptaminergic overstimulation on refeeding implicated in \u201cenlightenment\u201d experiences","volume":"79","author":"Joseph","year":"2012","journal-title":"Med. Hypotheses"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0306-3623(82)90087-8","article-title":"A possible role for tyramines in brain function and some mental disorders","volume":"13","author":"Juorio","year":"1982","journal-title":"Gen. Pharmacol. Vasc. Syst."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/02791072.2020.1815911","article-title":"Chemical composition of traditional and analog ayahuasca","volume":"53","author":"Kaasik","year":"2021","journal-title":"J. Psychoact. Drugs"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib132","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/00365510510013604","article-title":"Potentially hallucinogenic 5\u2010hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues","volume":"65","author":"K\u00e4rkk\u00e4inen","year":"2005","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"10.1016\/j.neuropharm.2025.110314_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112743","article-title":"Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease","volume":"255","author":"Katchborian-Neto","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"7270","key":"10.1016\/j.neuropharm.2025.110314_bib134","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature08506","article-title":"Predicting new molecular targets for known drugs","volume":"462","author":"Keiser","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1021\/acschemneuro.1c00660","article-title":"Pharmahuasca and DMT rescue ROS production and differentially expressed genes observed after predator and psychosocial stress: relevance to human PTSD","volume":"13","author":"Kelley","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"20","key":"10.1016\/j.neuropharm.2025.110314_bib136","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103079118","article-title":"A key requirement for synaptic Reelin signaling in ketamine-mediated behavioral and synaptic action","volume":"118","author":"Kim","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib137","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jchemneu.2009.06.010","article-title":"Aromatic l-amino acid decarboxylase-immunoreactive structures in human midbrain, pons, and medulla","volume":"38","author":"Kitahama","year":"2009","journal-title":"J. Chem. Neuroanat."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib252","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0891-0618(98)00060-X","article-title":"Aromatic L-amino acid decarboxylase-and tyrosine hydroxylase-immunohistochemistry in the adult human hypothalamus","volume":"16","author":"Kitahama","year":"1998","journal-title":"J. Chem. Neuroanat."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110314_bib138","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.tics.2012.10.007","article-title":"Alpha-band oscillations, attention, and controlled access to stored information","volume":"16","author":"Klimesch","year":"2012","journal-title":"Trends Cognit. Sci."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110314_bib139","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1267\/ahc.24.571","article-title":"Some neurons of the mouse cortex and caudoputamen contain aromatic L-amino acid decarboxylase but not monoamines","volume":"24","author":"Komori","year":"1991","journal-title":"Acta Histochem. Cytoc."},{"issue":"20","key":"10.1016\/j.neuropharm.2025.110314_bib140","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1073\/pnas.1322174111","article-title":"Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans","volume":"111","author":"Kox","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2025.110314_bib141","article-title":"The DMT and psilocin treatment changes CD11b+ activated microglia immunological phenotype [preprint]","author":"Koz\u0142owska","year":"2021","journal-title":"Cell Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib142","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jnc.15509","article-title":"From psychiatry to neurology: psychedelics as prospective therapeutics for neurodegenerative disorders","volume":"162","author":"Kozlowska","year":"2022","journal-title":"J. Neurochem."},{"issue":"47","key":"10.1016\/j.neuropharm.2025.110314_bib143","doi-asserted-by":"crossref","first-page":"9660","DOI":"10.1039\/D0OB01118E","article-title":"Quantum chemical (QM:MM) investigation of the mechanism of enzymatic reaction of tryptamine and N , N -dimethyltryptamine with monoamine oxidase A","volume":"18","author":"Kubicsk\u00f3","year":"2020","journal-title":"Org. Biomol. Chem."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110314_bib144","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","article-title":"The neural basis of psychedelic action","volume":"25","author":"Kwan","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110314_bib145","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/sj.npp.1300944","article-title":"Hallucinogen-induced UP states in the brain slice of rat prefrontal cortex: role of glutamate spillover and NR2B-NMDA receptors","volume":"31","author":"Lambe","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib146","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nn.3006","article-title":"Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1. 1 and acts in epilepsy","volume":"15","author":"Li","year":"2012","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib147","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0006-291X(73)91487-3","article-title":"Inhibition of indolethylamine-N-methyltransferase by S-Adenosylhomocysteine","volume":"54","author":"Lin","year":"1973","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110314_bib148","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/dev.420070511","article-title":"Indolethylamine-N-methyltransferase in developing rabbit lung","volume":"7","author":"Lin","year":"1974","journal-title":"Dev. Psychobiol."},{"key":"10.1016\/j.neuropharm.2025.110314_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113867","article-title":"Sigma\u20131 receptor activation alleviates blood\u2013brain barrier disruption post cerebral ischemia stroke by stimulating the GDNF\u2013GFR\u03b11\u2013RET pathway","volume":"347","author":"Liu","year":"2022","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0006-8993(00)02468-9","article-title":"Serotonin 5-HT2 receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus","volume":"873","author":"Liu","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110314_bib151","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7854_2017_478","article-title":"Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways","volume":"36","author":"L\u00f3pez-Gim\u00e9nez","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib152","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0021-9258(18)81366-7","article-title":"Aromatic l-amino acid decarboxylase","volume":"237","author":"Lovenberg","year":"1962","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110314_bib153","article-title":"Psychological and physiological effects of extended DMT","author":"Luan","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110314_bib154","article-title":"A role for the serotonin 2A receptor in the expansion and functioning of human transmodal cortex","volume":"awad311","author":"Luppi","year":"2023","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1556\/2054.2020.00143","article-title":"Entity encounters and the therapeutic effect of the psychedelic mystical experience","volume":"4","author":"Lutkajtis","year":"2021","journal-title":"Journal of Psychedelic Studies"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110314_bib156","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib157","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1021\/acsptsci.0c00065","article-title":"Transient stimulation with psychoplastogens is sufficient to initiate neuronal growth","volume":"4","author":"Ly","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib158","first-page":"47","article-title":"The biosynthesis of dimethyltryptamine in vivo","volume":"16","author":"Mandel","year":"1977","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110314_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.754502","article-title":"Intranasal delivery of nerve growth factor in neurodegenerative diseases and neurotrauma","volume":"12","author":"Manni","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"24","key":"10.1016\/j.neuropharm.2025.110314_bib160","doi-asserted-by":"crossref","first-page":"9856","DOI":"10.1523\/JNEUROSCI.21-24-09856.2001","article-title":"Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism","volume":"21","author":"Martin-Ruiz","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110314_bib161","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuroscience.2011.12.040","article-title":"Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N\u2032-dimethyltryptamine forming enzyme, indole-N-methyl transferase","volume":"206","author":"Mavlyutov","year":"2012","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2025.110314_bib162","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0161-813X(03)00098-6","article-title":"Tribulin and endogenous MAO-inhibitory regulation in vivo","volume":"25","author":"Medvedev","year":"2004","journal-title":"Neurotoxicology"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110314_bib163","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1471-4159.1977.tb10661.x","article-title":"Tetrahydro\u2010\u03b2\u2010carbolines: specific inhibitors of type A monoamine oxidase in rat brain 1","volume":"28","author":"Meller","year":"1977","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110314_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.590532","article-title":"Hypoxia routes tryptophan homeostasis towards increased tryptamine production","volume":"12","author":"Mohapatra","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110314_bib165","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110314_bib166","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0378-4347(00)82576-1","article-title":"Determination of pharmacological levels of harmane, harmine and harmaline in mammalian brain tissue, cerebrospinal fluid and plasma by high-performance liquid chromatography with fluorimetric detection","volume":"496","author":"Moncrieff","year":"1989","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib167","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41398-020-01011-0","article-title":"N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo","volume":"10","author":"Morales-Garcia","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib168","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1038\/s41598-017-05407-9","article-title":"The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro","volume":"7","author":"Morales-Garc\u00eda","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib169","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060863","article-title":"Stimulation of the sigma-1 receptor by DHEA enhances synaptic efficacy and neurogenesis in the hippocampal dentate gyrus of olfactory bulbectomized mice","volume":"8","author":"Moriguchi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110314_bib170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neulet.2015.02.004","article-title":"Live imaging reveals a new role for the sigma-1 (\u03c31) receptor in allowing microglia to leave brain injuries","volume":"591","author":"Moritz","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib171","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cca.2003.08.009","article-title":"Nitric oxide inhibits mitochondrial monoamine oxidase activity and decreases outer mitochondria membrane fluidity","volume":"136","author":"Muriel","year":"2003","journal-title":"Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib172","first-page":"27","article-title":"Structure-activity relationships among desmethyl derivatives of neuroleptics and antidepressants for substrate specificty to indolethylamine N-methyltransferase from rabbit lung","volume":"2","author":"Narasimhachari","year":"1976","journal-title":"Psychopharmacol. Commun."},{"key":"10.1016\/j.neuropharm.2025.110314_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113245","article-title":"N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats","volume":"327","author":"Nardai","year":"2020","journal-title":"Exp. Neurol."},{"issue":"7966","key":"10.1016\/j.neuropharm.2025.110314_bib174","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-023-06204-3","article-title":"Psychedelics reopen the social reward learning critical period","volume":"618","author":"Nardou","year":"2023","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib175","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.transproceed.2019.04.005","article-title":"N,N-dimethyltryptamine prevents renal ischemia-reperfusion injury in a rat model","volume":"51","author":"Nemes","year":"2019","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.neuropharm.2025.110314_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109232","article-title":"Psychedelics as potent anti-inflammatory therapeutics","volume":"219","author":"Nichols","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110314_bib177","author":"Nichols"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib178","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0269881117736919","article-title":"N,N -dimethyltryptamine and the pineal gland: separating fact from myth","volume":"32","author":"Nichols","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110314_bib179","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuroscience.2015.03.050","article-title":"Serotonin-2C and-2a receptor co-expression on cells in the rat medial prefrontal cortex","volume":"297","author":"Nocjar","year":"2015","journal-title":"Neuroscience"},{"issue":"14","key":"10.1016\/j.neuropharm.2025.110314_bib180","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1152\/physiolgenomics.00189.2010","article-title":"Cystathionine \u03b2-synthase deficiency causes infertility by impairing decidualization and gene expression networks in uterus implantation sites","volume":"44","author":"Nu\u00f1o-Ayala","year":"2012","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.neuropharm.2025.110314_bib181","doi-asserted-by":"crossref","DOI":"10.1177\/1179069518800508","article-title":"Psychoplastogens: a promising class of plasticity-promoting neurotherapeutics","volume":"12","author":"Olson","year":"2018","journal-title":"J. Exp. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110314_bib182","article-title":"Biochemical mechanisms underlying psychedelic-induced neuroplasticity","author":"Olson","year":"2022","journal-title":"Biochemistry, acs.biochem.1c00812."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib183","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.biochem.1c00812","article-title":"Biochemical mechanisms underlying psychedelic-induced neuroplasticity","volume":"61","author":"Olson","year":"2022","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib184","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00426775","article-title":"Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects","volume":"54","author":"Oon","year":"1977","journal-title":"Psychopharmacology"},{"issue":"34","key":"10.1016\/j.neuropharm.2025.110314_bib185","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.1523\/JNEUROSCI.0458-14.2014","article-title":"NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus","volume":"34","author":"Pabba","year":"2014","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib186","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1471-4159.2012.07664.x","article-title":"Glial cells in (patho) physiology","volume":"121","author":"Parpura","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110314_bib187","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1016\/j.ibneur.2023.08.605","article-title":"The AYAHUASCA\u2019S psychedelic component DMT potentiates neuritogenesis IN PC12 cells","volume":"15","author":"Pazos","year":"2023","journal-title":"IBRO Neuroscience Reports"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110314_bib188","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1164\/ajrccm\/148.5.1210","article-title":"Endogenous nitric oxide in single exhalations and the change during exercise","volume":"148","author":"Persson","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib189","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/CH-170361","article-title":"Hemorheological and metabolic consequences of renal ischemia-reperfusion and their modulation by N, N-dimethyl-tryptamine on a rat model","volume":"70","author":"Peto","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib190","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1601-183X.2012.00777.x","article-title":"Common transcriptional effects in the mouse striatum following chronic treatment with heroin and methamphetamine","volume":"11","author":"Piechota","year":"2012","journal-title":"Gene Brain Behav."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110314_bib191","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0020-711X(79)90124-1","article-title":"Multiple forms of rabbit lung indoleamine-N-methyltransferase","volume":"10","author":"Porta","year":"1979","journal-title":"Int. J. Biochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib192","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0301-0082(98)00097-5","article-title":"Serotonin and the sleep\/wake cycle: special emphasis on microdialysis studies","volume":"60","author":"Portas","year":"2000","journal-title":"Prog. Neurobiol."},{"issue":"13","key":"10.1016\/j.neuropharm.2025.110314_bib193","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1523\/JNEUROSCI.3451-13.2014","article-title":"Intracellular mGluR5 can mediate synaptic plasticity in the hippocampus","volume":"34","author":"Purgert","year":"2014","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib194","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0378-4347(00)81837-X","article-title":"Mass fragmentographic quantification of urinary N,N-dimethyltryptamine and bufotenine","volume":"162","author":"R\u00e4is\u00e4nen","year":"1979","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009019","article-title":"Psychedelics and the human receptorome","volume":"5","author":"Ray","year":"2010","journal-title":"PLoS One"},{"issue":"7\u20138","key":"10.1016\/j.neuropharm.2025.110314_bib196","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/dta.1344","article-title":"Metabolism and disposition of N, N\u2010dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca","volume":"4","author":"Riba","year":"2012","journal-title":"Drug Test. Anal."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib197","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0376-8716(00)00175-7","article-title":"Psychometric assessment of the hallucinogen rating scale","volume":"62","author":"Riba","year":"2001","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110314_bib198","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","article-title":"Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens","volume":"26","author":"Rickli","year":"2016","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"S1","key":"10.1016\/j.neuropharm.2025.110314_bib199","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40635-020-00307-1","article-title":"Pathophysiology and clinical consequences of arterial blood gases and pH after cardiac arrest","volume":"8","author":"Robba","year":"2020","journal-title":"Intensive Care Medicine Experimental"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1196\/annals.1304.018","article-title":"Endogenous \u03b2\u2010carbolines as clonidine\u2010displacing substances","volume":"1009","author":"Robinson","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib201","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/02791072.2019.1602291","article-title":"Dimethyltryptamine: endogenous role and therapeutic potential","volume":"51","author":"Rodrigues","year":"2019","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.neuropharm.2025.110314_bib202","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1055\/s-2006-960234","article-title":"\u03b2-Carbolines and tetrahydroisoquinolines: detection and function in mammals","volume":"57","author":"Rommelspacher","year":"2007","journal-title":"Planta Med."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110314_bib203","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/biom12111618","article-title":"Molecular pathways of the therapeutic effects of ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant","volume":"12","author":"Rossi","year":"2022","journal-title":"Biomolecules"},{"issue":"4028","key":"10.1016\/j.neuropharm.2025.110314_bib204","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.175.4028.1365","article-title":"Psychotomimetic N -methylated tryptamines: formation in brain in vivo and in vitro","volume":"175","author":"Saavedra","year":"1972","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib205","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1471-4159.1973.tb00035.x","article-title":"The distribution and properties of the nonspecific N-methyltransferase in brain","volume":"20","author":"Saavedra","year":"1973","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110314_bib206","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ijnp\/pyx036","article-title":"Assessing the psychedelic \u201cafter-glow\u201d in ayahuasca users: post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities","volume":"20","author":"Sampedro","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110314_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.jadr.2021.100098","article-title":"Ayahuasca use and reported effects on depression and anxiety symptoms: an international cross-sectional study of 11,912 consumers","volume":"4","author":"Sarris","year":"2021","journal-title":"Journal of Affective Disorders Reports"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110314_bib208","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11916-023-01145-y","article-title":"The potential of psychedelics for the treatment of episodic migraine","volume":"27","author":"Schindler","year":"2023","journal-title":"Curr. Pain Headache Rep."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib209","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0003-2697(85)90289-1","article-title":"High-performance liquid chromatography of tetrahydro-\u03b2-carbolines extracted from plasma and platelets","volume":"147","author":"Schouten","year":"1985","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib210","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/apha.12430","article-title":"The role of serotonin and its receptors in activation of immune responses and inflammation","volume":"213","author":"Shajib","year":"2015","journal-title":"Acta Physiol."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110314_bib211","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bjae.2022.06.003","article-title":"Acid\u2013base balance: a review of normal physiology","volume":"22","author":"Shaw","year":"2022","journal-title":"BJA Education"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib212","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1124\/jpet.115.229765","article-title":"In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1","volume":"357","author":"Simmler","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110314_bib213","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/0006-2952(87)90118-3","article-title":"In vivo metabolism of 5-methoxy-N, N-dimethyltryptamine and N,N-dimethyltryptamine in the rat","volume":"36","author":"Sitaram","year":"1987","journal-title":"Biochem. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2025.110314_bib214","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0006-8993(98)00538-1","article-title":"Studies on the interaction between 1,2,3,4-tetrahydro-\u03b2-carboline and cigarette smoke: a potential mechanism of neuroprotection for Parkinson's disease","volume":"802","author":"Soto-Otero","year":"1998","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib215","first-page":"171","article-title":"Plasma indolethylamine-n-methyltransferase activity and growth hormone level during sleep: a pilot study","volume":"12","author":"Strahilevitz","year":"1977","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110314_bib216","article-title":"DMT: the spirit molecule: a doctor's revolutionary research into the biology of near-death and mystical experiences","author":"Strassman","year":"2000","journal-title":"Inner Traditions\/Bear"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib217","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0166-4328(96)00081-2","article-title":"Human psychopharmacology of N,N-dimethyltryptamine","volume":"73","author":"Strassman","year":"1995","journal-title":"Behav. Brain Res."},{"issue":"23","key":"10.1016\/j.neuropharm.2025.110314_bib218","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1523\/JNEUROSCI.0839-12.2012","article-title":"GABAergic synaptic transmission triggers action potentials in thalamic reticular nucleus neurons","volume":"32","author":"Sun","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110314_bib219","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cophys.2019.01.003","article-title":"The many acid\u2013base manifestations and consequences of hypoxia","volume":"7","author":"Swenson","year":"2019","journal-title":"Current Opinion in Physiology"},{"key":"10.1016\/j.neuropharm.2025.110314_bib220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00358","article-title":"Psychedelics and immunomodulation: novel approaches and therapeutic opportunities","volume":"6","author":"Szabo","year":"2015","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib221","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4103\/1673-5374.179041","article-title":"Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?","volume":"11","author":"Szabo","year":"2016","journal-title":"Neural Regeneration Research"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110314_bib222","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106533","article-title":"Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells","volume":"9","author":"Szabo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110314_bib223","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fnins.2016.00423","article-title":"The endogenous hallucinogen and trace amine N, N-dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary iPSC-derived cortical neurons and microglia-like immune cells","volume":"10","author":"Szabo","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110314_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108612","article-title":"N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain","volume":"192","author":"Szab\u00f3","year":"2021","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib225","first-page":"201","article-title":"DMT at fifty","volume":"9","author":"Sz\u00e1ra","year":"2007","journal-title":"Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110314_bib226","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0020-708X(85)90257-1","article-title":"11C-labelling of indolealkylamine alkaloids and the comparative study of their tissue distributions","volume":"36","author":"Takahashi","year":"1985","journal-title":"Int. J. Appl. Radiat. Isot."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110314_bib227","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0006-291X(72)90712-7","article-title":"Substrate specificity and heterogeneity of N-methyltransferases","volume":"47","author":"Thithapandha","year":"1972","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib228","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/geno.1999.5960","article-title":"Human indolethylamine N-methyltransferase: cDNA cloning and expression, gene cloning, and chromosomal localization","volume":"61","author":"Thompson","year":"1999","journal-title":"Genomics"},{"issue":"13","key":"10.1016\/j.neuropharm.2025.110314_bib229","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2218949120","article-title":"Human brain effects of DMT assessed via EEG-fMRI","volume":"120","author":"Timmermann","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib230","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51974-4","article-title":"Neural correlates of the DMT experience assessed with multivariate EEG","volume":"9","author":"Timmermann","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110314_bib231","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3389\/fpsyg.2018.01424","article-title":"DMT models the near-death experience","volume":"9","author":"Timmermann","year":"2018","journal-title":"Front. Psychol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib232","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1254\/jjp.66.67","article-title":"Acetylcholine measurement of cerebrospinal fluid by in vivo microdialysis in freely moving rats","volume":"66","author":"Togashi","year":"1994","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110314_bib233","first-page":"79","article-title":"Sigma-1 receptors fine-tune the neuronal networks","volume":"vol. 964","author":"Tsai","year":"2017"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib234","first-page":"12","article-title":"Psychoactive natural products: overview of recent developments","volume":"50","author":"Ujv\u00e1ry","year":"2014","journal-title":"Annali dell'Istituto superiore di sanita"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib235","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00965576","article-title":"Adaptive changes induced by high altitude in the development of brain monoamine enzymes","volume":"3","author":"Vaccari","year":"1978","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2025.110314_bib236","article-title":"Role of 5-HT2A receptor antagonists in the treatment of insomnia","volume":"139","author":"Vanover","year":"2010","journal-title":"Nat. Sci. Sleep"},{"issue":"6633","key":"10.1016\/j.neuropharm.2025.110314_bib237","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors","volume":"379","author":"Vargas","year":"2023","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110314_bib238","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2967\/jnumed.110.083246","article-title":"In vivo long-term kinetics of radiolabeled N , N -dimethyltryptamine and tryptamine","volume":"52","author":"Vitale","year":"2011","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110314_bib239","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41398-023-02477-4","article-title":"Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants","volume":"13","author":"Vogt","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110314_bib241","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0893-133X(99)00163-3","article-title":"Antagonism of a PCP drug discrimination by hallucinogens and related drugs","volume":"22","author":"West","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib242","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1471-4159.1983.tb08113.x","article-title":"Inhibition of synaptosomal neurotransmitter uptake by hallucinogens","volume":"40","author":"Whipple","year":"1983","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110314_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106803","article-title":"Novel extended-release transdermal formulations of the psychedelic N,N-dimethyltryptamine (DMT)","volume":"199","author":"Witowski","year":"2024","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110314_bib244","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.3390\/ijms23126713","article-title":"Effect of psilocybin and ketamine on brain neurotransmitters, glutamate receptors, DNA and rat behavior","volume":"23","author":"Wojtas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00276707","article-title":"In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N, N-[11 C] dimethyltryptamine","volume":"12","author":"Yanai","year":"1986","journal-title":"Eur. J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib246","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00276707","article-title":"In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N, N-[11C] dimethyltryptamine","volume":"12","author":"Yanai","year":"1986","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.neuropharm.2025.110314_bib247","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fphar.2019.00528","article-title":"The roles of intracellular chaperone proteins, sigma receptors, in Parkinson's disease (PD) and major depressive disorder (MDD)","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110314_bib248","doi-asserted-by":"crossref","first-page":"563","DOI":"10.18388\/abp.2004_3545","article-title":"HIF-1: the knowns and unknowns of hypoxia sensing","volume":"51","author":"Zag\u00f3rska","year":"2004","journal-title":"Acta Biochim. Pol."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110314_bib249","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1167\/iovs.13-12823","article-title":"Sigma receptor ligand, (+)-Pentazocine, suppresses inflammatory responses of retinal microglia","volume":"55","author":"Zhao","year":"2014","journal-title":"Investigative Opthalmology & Visual Science"},{"key":"10.1016\/j.neuropharm.2025.110314_bib250","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10495-018-1495-2","article-title":"Sigma-1 receptor protects against endoplasmic reticulum stress-mediated apoptosis in mice with cerebral ischemia\/reperfusion injury","volume":"24","author":"Zhao","year":"2019","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110314_bib251","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/PSY.0000000000001065","article-title":"The effects of cold exposure training and a breathing exercise on the inflammatory response in humans: a pilot study","volume":"84","author":"Zwaag","year":"2022","journal-title":"Psychosom. Med."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825000206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825000206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:57:51Z","timestamp":1762214271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825000206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":245,"alternative-id":["S0028390825000206"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110314","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring DMT: Endogenous role and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110314"}}